1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Chison Medical Technologies Co. Ltd. Class A

Chison Medical Technologies Co. Ltd. Class A

SSSE:688358
25.77
CNY
-0.51
(-1.94%)
1.07EPS
28.65P/E
3.43BMarket Cap
Oct 28Next Earn
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2
3.24
3.88
4.27
2.98
3.54
3.38
4.39
4.2
3.89
3.95
Basic EPS, GAAP
0.36
0.76
1.13
1.21
0.89
1
0.94
1.33
1.26
1.04
1.07
Free Cash Flow per Basic Share
0.41
0.57
0.78
0.83
0.46
0.01
0.1
0.47
1.18
0.83
- -
Dividend per Share
0.36
0.16
0.22
0.94
0.72
0.57
0.36
0.71
0.8
1
0.3
Book Value per Share
0.91
1.72
2.49
10.45
10.65
11.12
11.71
12.21
12.67
12.34
12.2
Tangible Book Value per Share
0.88
1.42
2.19
10.24
10.44
10.92
11.52
12.02
12.49
12.15
12.01
Basic Weighted Avg Shares
84
84
84
87
112
112
113
110
112
112
112
Sales/Revenue/Turnover
167
272
327
370
333
398
381
484
469
436
443
Operating Margin (%)
14.86
28.64
32.46
30.65
27.18
21.78
20.44
27.08
23.89
22.99
24.64
Depreciation Expense
5
5
6
7
8
10
13
14
15
14
- -
Net Income, GAAP
30
64
95
105
100
112
106
146
141
116
120
Effective Tax Rate (%)
9.1
13.47
11.22
10.86
10.65
9.69
8.07
9.69
10.42
9.44
9.88
Profit Margin (%)
18.25
23.58
29.07
28.43
29.91
28.27
27.79
30.27
29.98
26.73
27.03
Working Capital
52
112
184
1,145
1,141
1,131
1,150
1,203
1,238
1,211
1,196
LT Debt
- -
- -
- -
- -
1
1
6
6
3
2
4
Total Equity
76
144
209
1,171
1,193
1,246
1,314
1,369
1,421
1,383
1,368
Return on Invested Capital (%)
- -
53.34
50.95
14.9
8.23
9.26
8.25
10.87
10.06
8.19
7.87
Return on Capital (%)
- -
62.36
53.64
15.17
8.33
9.03
8.08
9.63
10.04
8.3
8.44
Return on Common Equity (%)
- -
58.09
53.81
15.24
8.43
9.22
8.27
10.92
10.07
8.31
8.45

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
2
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
112
112
Market Capitalization
3,375
3,262
3,428

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,407
1,385
1,410
Cash, Cash Equivalents & STI
1,068
1,005
1,032
Accounts Receivable, Net
189
220
206
Inventories
129
139
146
Total Current Liabilities
196
136
214
Payables & Accruals
- -
- -
- -
ST Debt
1
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
3.05%
-2.61%
Free Cash Flow
- -
352.56%
-29.64%
Net Income, GAAP
- -
4.84%
-17.09%
Sales/Revenue/Turnover
- -
6.41%
-7.02%
Total Cash Common Dividend
- -
15.55%
25%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
141
107
115
106
469
2025
128
108
- -
93
436
2026
127
114
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.41
0.32
0.15
0.38
1.26
2025
0.37
0.25
- -
0.2
1.04
2026
0.41
0.2
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.51
0.8
2025
- -
- -
- -
- -
1
2026
0.3
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ruo Li Mo
Full Time Employees
467
Sector
Health technology
Industry
Medical specialties
Address
No.3 Changjiang South Road Wuxi JS China 214028
IPO Date
Dec 3, 2019
Website
chison.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Chison Medical Technologies Co., Ltd. Chison Medical Technologies Co., Ltd. (688358.SS) manufactures and sells diagnostic ultrasound systems principally for medical imaging applications in China and internationally. The company offers a broad portfolio of ultrasound equipment, including cart-based systems, portable ultrasound devices, handheld ultrasound probes, black-and-white (B&W) ultrasound models, and high-performance color Doppler systems; its SonoFamily product line encompasses SonoMax, SonoAir, and SonoEye series for point-of-care, general imaging, women's health, cardiovascular, radiology, vascular, musculoskeletal (MSK), obstetrics, anesthesiology, emergency, and veterinary uses; supporting equipment includes mobile, vehicle-mounted imaging devices, related instrumentation, electronic components, and accessories. Founded in 1996 and headquartered in Wuxi, Jiangsu Province, China, Chison Medical Technologies maintains research and development centers in China and the United States, with sales networks spanning more than 100 countries and certifications including FDA, CE, and KFDA. The company operates primarily in the medical devices sector, targeting hospitals, clinics, scientific research institutions, and strategic partners across domestic and overseas markets in departments such as ultrasound, obstetrics and gynecology, cardiology, oncology, and pain management. Recent developments include the grand opening of the CHISON Global Ultrasound Training Center and the launch of SonoPort, the newest member of the SonoFamily series, in 2024; a strategic cooperation agreement with EverBridge Medical in April 2024 to advance global ultrasound solutions and "clinical + ultrasound" innovations; and the 2023 introduction of the expanded SonoFamily lineup transforming portable ultrasound offerings.